Review of treatment trials in humanspinal cord injury: Issues, difficulties, and recommendations

Neurosurgery

Volumn 59, Issue 5, 2006, Pages 957-982

  Tator, Charles H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Human spinal cord injury; Review; Treatment trials

Indexed keywords

4 AMINOPYRIDINE; ACIDIC FIBROBLAST GROWTH FACTOR; ANTIBODY; BRAIN DERIVED NEUROTROPHIC FACTOR; CETHRIN; CILIARY NEUROTROPHIC FACTOR; GACYCLIDINE; GANGLIOSIDE GM1; MACROGOL; METHYLPREDNISOLONE; MINOCYCLINE; NALOXONE; NERISPIRDINE; NEUROTROPHIC FACTOR; NIMODIPINE; NOGO A ANTIBODY; POTASSIUM CHANNEL BLOCKING AGENT; PROTIRELIN; RHO KINASE INHIBITOR; SODIUM CHANNEL BLOCKING AGENT; TIRILAZAD; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONVALESCENCE; CORD BLOOD STEM CELL TRANSPLANTATION; DECOMPRESSION SURGERY; DRUG EFFICACY; ELECTROSTIMULATION; EMBRYONIC STEM CELL; EVOKED SOMATOSENSORY RESPONSE; EXERCISE; HUMAN; INJURY SEVERITY; LOCOMOTION; MOBILIZATION; MYOPATHY; NERVE GRAFT; NERVE REGENERATION; NEUROPROTECTION; NEUROSURGERY; NONHUMAN; OCCUPATIONAL THERAPY; OLFACTORY BULB; OLFACTORY ENSHEATHING CELL; PERIPHERAL BLOOD STEM CELL; PHYSIOTHERAPY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCHWANN CELL; SCORING SYSTEM; SEPSIS; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

DATA COLLECTION; HUMANS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 33845207898     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000245591.16087.89     Document Type: Review

References (179)

1. Anonymous: Guidelines for management of acute cervical spinal injuries. Introduction. Neurosurgery 50: [Suppl3]S1-S199, 2002.
2. Anonymous: Clinical Practice Guidelines. Consortium for Spinal Cord Medicine. Paralyzed Veterans of America, 2005.
3. Anonymous: National Institutes of Health: ClinicalTrials.gov. Available at: www.clinicaltrials.gov. Accessed January 3, 2006.
4. Amador MJ, Guest JD: An appraisal of ongoing experimental procedures in human spinal cord injury. J Neurol Phys Ther 29:70-86, 2005.
5. Anderson DK, Beattie M, Blesch A, Bresnahan J, Bunge M, Dietrich D, Dietz V, Dobkin B, Fawcett J, Fehlings M, Fischer I, Grossman R, Guest J, Hagg T, Hall ED, Houle J, Kleitman N, McDonald J, Murray M, Privat A, Reier P, Steeves J, Steward O, Tetzlaff W, Tuszynski MH, Waxman SG, Whittemore S, Wolpaw J, Young W, Zheng B: Recommended guidelines for studies of human subjects with spinal cord injury. Spinal Cord 43:453-458, 2005.
6. Anderson KD: Targeting recovery: Priorities of the spinal cord-injured population. J Neurotrauma 21:1371-1383, 2004.
7. Bareyre FM, Schwab ME: Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci 26:555-563, 2003.
8. Barros TE, Oliveira R, Barros EM, Junior RM, Cristante AF, Marcon RM, Azze R: The use of peripheral nerve bridges to spinal cord injury. J Spinal Cord Med 26:S33, 2003.
9. Bedbrook G: Recovery of spinal cord function. Paraplegia 18:315-323, 1980.
10. Berry DA: Clinical trials: Is the Bayesian approach ready for prime time? Yes! Stroke 36:1621-1622, 2005.
11. Berry DA: Introduction to Bayesian methods III: Use and interpretation of Bayesian tools in design and analysis. Clin Trials 2:295-300, 2005.
12. Berry DA: Bayesian clinical trials. Nat Rev Drug Discov 5:27-36, 2006.
13. Blight AR: Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Res Bull 22:47-52, 1989.
14. Borgens RB, Blight AR, McGinnis ME: Behavioral recovery induced by applied electric fields after spinal cord hemisection in guinea pig. Science 238:366-369, 1987.
15. Borgens RB, Shi R: Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol. FASEB J 14:27-35, 2000.
16. Bracken MB: Methylprednisolone in the management of acute spinal cord injuries. Med J Aust 153:368, 1990.
17. Bracken MB: Steroids for acute spinal cord injury. (Cochrane Review). Cochrane Database System Reviews Issue 2, CD001046, 2002.
18. Bracken MB: Steroids for acute spinal cord injury (Cochrane Review), in The Cochrane Library. Oxford, Update Software, 2006, issue 3.
19. Bracken MB, Collins WF, Freeman DF, Shepard MJ, Wagner FW, Silten RM, Hellenbrand KG, Ransohoff J, Hunt WE, Perot PL Jr, Grossman RG, Green BA, Eisenberg HM, Rifkinson N, Goodman JH, Meagher JN, Fischer B, Clifton GL, Flamm ES, Rawe SE: Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251:45-52, 1984.
20. Bracken MB, Holford TR: Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. J Neurosurg 79:500-507, 1993.
21. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J, Marshall LF, Perot PL Jr, Piepmeier JM, Sonntag VK, Wagner FC, Wilberger JE, Winn HR: A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322:1405-1411, 1990.
22. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings M, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmeier JM, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W: Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277:1597-1604, 1997.
23. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB: Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636-640, 2002.
24. Brunelli GA: Direct neurotization of muscles by presynaptic motoneurons. J Reconstr Microsurg 17:631-636, 2001.
25. Burns AS, Lee BS, Ditunno JF Jr, Tessler A: Patient selection for clinical trials: The reliability of the early spinal cord injury examination. J Neurotrauma 20:477-482, 2003.
26. Carlstedt T, Anand P, Hallin R, Misra PV, Noren G, Seferlis T: Spinal nerve root repair and reimplantation of avulsed ventral roots into the spinal cord after brachial plexus injury. J Neurosurg 93:237-247, 2000.
27. Casha S, Yu WR, Fehlings MG: Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103:203-218, 2001.
28. Casha S, Yu WR, Fehlings MG: FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp Neurol 196: 390-400, 2005.
29. Catz A, Itzkovich M, Agranov E, Ring H, Tamir A: The spinal cord independence measure (SCIM): Sensitivity to functional changes in subgroups of spinal cord lesion patients. Spinal Cord 39:97-100, 2001.
30. Catz A, Itzkovich M, Steinberg F, Philo O, Ring H, Ronen J, Spasser R, Gepstein R, Tamir A: The Catz-Itzkovich SCIM: A revised version of the Spinal Cord Independence Measure. Disabil Rehabil 23:263-268, 2001.
31. Cesaro P: The design of clinical trials for cell transplantation into the central nervous system. NeuroRx 1:492-499, 2004.
32. Cheng H, Cao Y, Olson L: Spinal cord repair in adult paraplegic rats: Partial restoration of hind limb function. Science 273:510-513, 1996.
33. Cheng H, Liao KK, Liao SF, Chuang TY, Shih YH: Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia. Spine 29:E284-E288, 2004.
34. Chinnock P, Roberts I: Gangliosides for acute spinal cord injury. Cochrane Database Systematic Reviews Issue 3, CD004444, 2006.
35. Chopp M, Zhang XH, Li Y, Wang L, Chen J, Lu D, Lu M, Rosenblum M: Spinal cord injury in rat: Treatment with bone marrow stromal cell transplantation. Neuroreport 11:3001-3005, 2000.
36. Clifton GL, Donovan WH, Dimitrijevic MM, Allen SJ, Ku A, Potts JR 3rd, Moody FG, Boake C, Sherwood AM, Edwards JV: Omental transposition in chronic spinal cord injury. Spinal Cord 34:193-203, 1996.
37. Cohen M, Sheehan T, Herbison G: Content validity and reliability of the international standards for neurological classification of spinal cord injury. Top in Spinal Cord Inj Rehabilitation 1:15-31, 1996.
38. Coleman WP, Benzel D, Cahill DW, Ducker T, Geisler F, Green B, Gropper MR, Goffin J, Madsen PW 3rd, Maiman DJ, Ondra SL, Rosner M, Sasso RC, Trost GR, Zeidman S: A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord 13:185-199, 2000.
39. Cotman CW, Berchtold NC: Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25:295-301, 2002.
40. Cotman CW, Engesser-Cesar C: Exercise enhances and protects brain function. Exerc Sport Sci Rev 30:75-79, 2002.
41. Curt A, Schwab ME, Dietz V: Providing the clinical basis for new interventional therapies: Refined diagnosis and assessment of recovery after spinal cord injury. Spinal Cord 42:1-6, 2004.
42. De Girolami U, Frosch MP, Tator CH: Diseases of the spinal cord and vertebral column, in Graham DI, Lantos P (eds): Greenfield's Neuropathology. London, Arnold Publishers, 2002, ed 7, pp 1063-1101.
43. DeForge D, Nymark J, Lemaire E, Gardner S, Hunt M, Martel L, Curran D, Barbeau H: Effect of 4-aminopyridine on gait in ambulatory spinal cord injuries: A double-blind, placebo-controlled, crossover trial. Spinal Cord 42:674-685, 2004.
44. Dietz V, Colombo G: Recovery from spinal cord injury-underlying mechanisms and efficacy of rehabilitation. Acta Neurochir Suppl 89:95-100, 2004.
45. Ditunno J, Flanders A, Kirshblum S, Graziani V, Tessler A: Predicting outcome in traumatic spinal cord injury, in Kirshblum C, DeLisa JA (ed): Spinal Cord Medicine. Philadelphia, Lippincott Williams & Wilkins, 2002, pp 108-122.
46. Ditunno JF Jr, Ditunno PL, Graziani V, Scivoletto G, Bernardi M, Castellano V, Marchetti M, Barbeau H, Frankel HL, D'Andrea Greve JM, Ko HY, Marshall R, Nance P: Walking index for spinal cord injury (WISCI): An international multicenter validity and reliability study. Spinal Cord 38:234-243, 2000.
47. Dobkin BH, Apple D, Barbeau H, Basso M, Behrman A, Deforge D, Ditunno J, Dudley G, Elashoff R, Fugate L, Harkema S, Saulino M, Scott M: Methods for a randomized trial of weight-supported treadmill training versus conventional training for walking during inpatient rehabilitation after incomplete traumatic spinal cord injury. Neurorehabil Neural Repair 17:153-167, 2003.
48. Dobkin BH, Curt A, Guest J: Cellular transplants in China: Observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair 20:5-13, 2006.
49. Dobkin BH, Havton LA: Basic advances and new avenues in therapy of spinal cord injury. Annu Rev Med 55:255-282, 2004.
50. Dubreuil CI, Winton MJ, McKerracher L: Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J Cell Biol 162:233-243, 2003.
51. Duh MS, Shepard MJ, Wilberger JE, Bracken MB: The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment. Neurosurgery 35:240-249, 1994.
52. Ellaway PH, Anand P, Bergstrom EM, Catley M, Davey NJ, Frankel HL, Jamous A, Mathias C, Nicotra A, Savic G, Short D, Theodorou S: Towards improved clinical and physiological assessments of recovery in spinal cord injury: A clinical initiative. Spinal Cord 42:325-337, 2004.
53. Falci S, Holtz A, Akesson E, Azizi M, Ertzgaard P, Hultling C, Kjaeldgaard A, Levi R, Ringden O, Westgren M, Lammertse D, Seiger A: Obliteration of a posttraumatic spinal cord cyst with solid human embryonic spinal cord grafts: First clinical attempt. J Neurotrauma 14:875-884, 1997.
54. Fehlings MG, Baptiste DC: Current status of clinical trials for acute spinal cord injury. Injury 36 [Suppl 2]:B113-B122, 2005.
55. Fehlings MG, Rao SC, Tator CH, Skaf G, Arnold P, Benzel E, Dickman C, Cuddy B, Green B, Hitchon P, Northrup B, Sonntag VKH, Wagner F, Wilberger J: The optimal radiologic method for assessing spinal canal compromise and cord compression in patients with cervical spinal cord injury. Part II: Results of a multicenter study. Spine 24:605-613, 1999.
56. Fehlings MG, Sekhon LH, Tator C: The role and timing of decompression in acute spinal cord injury: What do we know? What should we do? Spine 26[Suppl 24]:S101-110, 2001.
57. Fehlings MG, Tator CH: An evidence-based review of decompressive surgery in acute spinal cord injury: Rationale, indications, and timing based on experimental and clinical studies. J Neurosurg 91 [Suppl 1]:1-11, 1999.
58. Feron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S, Geraghty T, Mackay-Sim A: Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 128:2951-2960, 2005.
59. Frankel HL, Hancock DO, Hyslop G, Melzak J, Michaelis LS, Ungar GH, Vernon JD, Walsh JJ: The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia 7:179-192, 1969.
60. Geisler FH: GM-1 ganglioside and motor recovery following human spinal cord injury. J Emerg Med 11 [Suppl 1]:49-55, 1993.
61. Geisler FH, Coleman WP, Grieco G, Poonian D: Measurements and recovery patterns in a multicenter study of acute spinal cord injury. Spine 26[Suppl 24]:S68-S86, 2001.
62. Geisler FH, Coleman WP, Grieco G, Poonian D: Recruitment and early treatment in a multicenter study of acute spinal cord injury. Spine 26 [Suppl 24]:S58-S67, 2001.
63. Geisler FH, Coleman WP, Grieco G, Poonian D, Sysgen Study Group: The Sygen multicenter acute spinal cord injury study. Spine 26 [Suppl 24]:S87-S98, 2001.
64. Geisler FH, Dorsey FC, Coleman WP: Recovery of motor function after spinal-cord injury: A randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med 324:1829-1838, 1991.
65. Goldsmith HS, Duckett S, Chen WF: Spinal cord vascularization by intact omentum. Am J Surg 129:262-265, 1975.
66. Goldsmith HS, Fonseca A Jr, Porter J: Spinal cord separation: MRI evidence of healing after omentum-collagen reconstruction. Neurol Res 27: 115-123, 2005.
67. Gomez-Pinilla F, Ying Z, Opazo P, Roy RR, Edgerton VR: Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle. Eur J Neurosci 13:1078-1084, 2001.
68. Goodkin R, Budzilovich GN, Campbell JB: Myelorrhaphy. Part 2. Spine 1:193-196, 1976.
69. Grijalva I, Guizar-Sahagun G, Castaneda-Hernandez G, Mino D, Maldonado-Julian H, Vidal-Cantu G, Ibarra A, Serra O, Salgado-Ceballos H, Arenas-Hernandez R: Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: A randomized, double-blind, placebo-controlled trial. Pharmacotherapy 23:823-834, 2003.
70. Gruner JA, Yee AK: 4-Aminopyridine enhances motor evoked potentials following graded spinal cord compression injury in rats. Brain Res 816: 446-456, 1999.
71. Guest J, Herrera LP, Qian T: Rapid recovery of segmental neurological function in a tetraplegic patient following transplantation of fetal olfactory bulb-derived cells. Spinal Cord 44:135-142, 2006.
72. Hadley MN, Walters BC, Grabb PA, Oyesiku NM, Przybylski GJ, Resnick DK, Ryken TC, Mielke DH: Guidelines for the management of acute cervical spine and spinal cord injuries. Clin Neurosurg 49:407-498, 2002.
73. Hall ED, Springer JE: Neuroprotection and acute spinal cord injury: A reappraisal. NeuroRx 1:80-100, 2004.
74. Hansebout R: Comprehensive review of methods of improving cord recovery after acute spinal cord injury, in Tator C (ed): Early Management of Acute Spinal Cord Injury. New York, Raven Press, 1982, pp 181-196.
75. Haug C, Gotzsche PC, Schroeder TV: Registries and registration of clinical trials. N Engl J Med 353:2811-2812, 2005.
76. Herman R, He J, D'Luzansky S, Willis W, Dilli S: Spinal cord stimulation facilitates functional walking in a chronic, incomplete spinal cord injured. Spinal Cord 40:65-68, 2002.
77. Hofstetter CP, Holmstrom NA, Lilja JA, Schweinhardt P, Hao J, Spenger C, Wiesenfeld-Hallin Z, Kurpad SN, Frisen J, Olson L: Allodynia limits the usefulness of intraspinal neural stem cell grafts; Directed differentiation improves outcome. Nat Neurosci 8:346-353, 2005.
78. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ, Olson L: Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 99:2199-2204, 2002.
79. Huang H, Chen L, Wang H, Xiu B, Li B, Wang R, Zhang J, Zhang F, Gu Z, Li Y, Song Y, Hao W, Pang S, Sun J: Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl) 116:1488-1491, 2003.
80. Hugenholtz H: Methylprednisolone for acute spinal cord injury: not a standard of care. CMAJ 168:1145-1146, 2003.
81. Hugenholtz H, Cass DE, Dvorak MF, Fewer DH, Fox RJ, Izukawa DM, Lexchin J, Tuli S, Bharatwal N, Short C: High-dose methylprednisolone for acute closed spinal cord injury - Only a treatment option. Can J Neurol Sci 29:227-235, 2002.
82. Hurlbert RJ: Methylprednisolone for acute spinal cord injury: An inappropriate standard of care. J Neurosurg 93 [Suppl 1]:1-7, 2000.
83. Hurlbert RJ: The role of steroids in acute spinal cord injury: An evidence-based analysis. Spine 26 [Suppl 24]:S39-S46, 2001.
84. Janson CG, Ramesh TM, During MJ, Leone P, Heywood J: Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. J Hematother Stem Cell Res 10:913-915, 2001.
85. Jonasson O: The importance of registering clinical trials. J Am Coll Surg 202:A30-A32, 2006.
86. Joshi M, Fehlings MG: Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma 19:175-190, 2002.
87. Kalra S, Genge A, Arnold DL: A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: Feasibility and results. Amyotroph Lateral Scler Other Motor Neuron Disord 4:22-26, 2003.
88. Katoh S, el Masry WS: Motor recovery of patients presenting with motor paralysis and sensory sparing following cervical spinal cord injuries. Paraplegia 33:506-509, 1995.
89. Keirstead HS: Stem cells for the treatment of myelin loss. Trends Neurosci 28:677-683, 2005.
90. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O: Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25:4694-4705, 2005.
91. Keith RA, Granger CV, Hamilton BB, Sherwin FS: The functional independence measure: A new tool for rehabilitation. Adv Clin Rehabil 1:6-18, 1987.
92. Kleitman N: Keeping promises: Translating basic research into new spinal cord injury therapies. J Spinal Cord Med 27:311-318, 2004.
93. Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R, Marder JB, Yoles E, Belkin M, Schwartz M, Hadani M: Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results. J Neurosurg Spine 3:173-181, 2005.
94. Kohama I, Lankford KL, Preiningerova J, White FA, Vollmer TL, Kocsis JD: Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci 21:944-950, 2001.
95. Krleza-Jeric K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C: Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ 330:956-958, 2005.
96. Kulbatski I, Mothe AJ, Nomura H, Tator CH: Endogenous and exogenous CNS derived stem/progenitor cell approaches for neurotrauma. Curr Drug Targets 6:111-126, 2005.
97. Kuppuswamy A, Theodorou S, Catley M, Strutton PH, Ellaway PH, McGregor AH, Davey NJ: Motor neurone excitability in back muscles assessed using mechanically evoked reflexes in spinal cord injured patients. J Neurol Neurosurg Psychiatry 76:1259-1263, 2005.
98. Kwon BK, Fisher CG, Dvorak MF, Tetzlaff W: Strategies to promote neural repair and regeneration after spinal cord injury. Spine 30 [Suppl 17]:S3-S13, 2005.
99. La Rosa G, Conti A, Cardali S, Cacciola F, Tomasello F: Does early decompression improve neurological outcome of spinal cord injured patients? Appraisal of the literature using a meta-analytical approach. Spinal Cord 42:503-512, 2004.
100. Ladouceur M, Barbeau H: Functional electrical stimulation-assisted walking for persons with incomplete spinal injuries: longitudinal changes in maximal overground walking speed. Scand J Rehabil Med 32:28-36, 2000.
101. Lammertse DP: Update on pharmaceutical trials in acute spinal cord injury. J Spinal Cord Med 27:319-325, 2004.
102. Lee SM, Yune TY, Kim SJ, Park do W, Lee YK, Kim YC, Oh YJ, Markelonis GJ, Oh TH: Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma 20:1017-1027, 2003.
103. Lehmann M, Fournier A, Selles-Navarro I, Dergham P, Sebok A, Leclerc N, Tigyi G, McKerracher L: Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci 19:7537-7547, 1999.
104. Li S, Liu BP, Budel S, Li M, Ji B, Walus L, Li W, Jirik A, Rabacchi S, Choi E, Worley D, Sah DW, Pepinsky B, Lee D, Relton J, Strittmatter SM: Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci 24:10511-10520, 2004.
105. Li S, Strittmatter SM: Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci 23:4219-4227, 2003.
106. Li Y, Field PM, Raisman G: Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J Neurosci 18: 10514-10524, 1998.
107. Lima C: Clinical trials: Vulnerability and ethical relativism [in Portuguese]. Acta Med Port 18:221-226, 2005.
108. Lucas JT, Ducker TB: Motor classification of spinal cord injuries with mobility, morbidity and recovery indices. Am Surg 45:151-158, 1979.
109. Marino RJ, Barros T, Biering-Sorensen F, Burns SP, Donovan WH, Graves DE, Haak M, Hudson LM, Priebe MM, ASIA Neurological Standards Committee: International standards for neurological classification of spinal cord injury. J Spinal Cord Med 26 [Suppl 1]:S50-S56, 2003.
110. Marino RJ, Ditunno JF Jr, Donovan WH, Maynard F Jr: Neurologic recovery after traumatic spinal cord injury: Data from the Model Spinal Cord Injury Systems. Arch Phys Med Rehabil 80:1391-1396, 1999.
111. Marino RJ, Graves DE: Metric properties of the ASIA motor score: Subscales improve correlation with functional activities. Arch Phys Med Rehabil 85:1804-1810, 2004.
112. McDonald JW, Becker D, Sadowsky CL, Jane JA Sr, Conturo TE, Schultz LM: Late recovery following spinal cord injury. Case report and review of the literature. J Neurosurg 97 [Suppl 2]:252-265, 2002.
113. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, Gottlieb DI, Choi DW: Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5:1410-1412, 1999.
114. Neeper SA, Gomez-Pinilla F, Choi J, Cotman C: Exercise and brain neurotrophins. Nature 373:109, 1995.
115. Nesathurai S: Steroids and spinal cord injury: Revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma 45:1088-1093, 1998.
116. Otani K, Abe H, Kadoya S, Nakagowa H, Ikata T, Tominaga S, Arima T, Ohtsuka T, Ohwada T, Aikawa N, Hanaoka K: Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury [in Japanese]. Sekitsui Sekizui J 7:633-647, 1994.
117. Park HC, Shim YS, Ha Y, Yoon SH, Park SR, Choi BH, Park HS: Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 11:913-922, 2005.
118. Pearson H: In search of a miracle. Nature 423:112-113, 2003.
119. Penn RD, Kroin JS, York MM, Cedarbaum JM: Intrathecal ciliary neurotrophic factor delivery for treatment of amyotrophic lateral sclerosis (phase I trial). Neurosurgery 40:94-100, 1997.
120. Pitts LH, Ross A, Chase GA, Faden AI: Treatment with thyrotropin- releasing hormone (TRH) in patients with traumatic spinal cord injuries. J Neurotrauma 12:235-243, 1995.
121. Pointillart V, Petitjean ME, Wiart L, Vital JM, Lassie P, Thicoipe M, Dabadie P: Pharmacological therapy of spinal cord injury during the acute phase. Spinal Cord 38:71-76, 2000.
122. Qian T, Guo X, Levi AD, Vanni S, Shebert RT, Sipski ML: High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord 43:199-203, 2005.
123. Rabinovich SS, Seledtsov VI, Poveschenko OV, Senuykov VV, Taraban VY, Yarochno VI, Kolosov NG, Savchenko SA, Kozlov VA: Transplantation treatment of spinal cord injury patients. Biomed Pharmacother 57:428-433, 2003.
124. Ragnarsson KT, Wuermser LA, Cardenas DD, Marino RJ: Spinal cord injury clinical trials for neurologic restoration: improving care through clinical research. Am J Phys Med Rehabil 84 [Suppl 11]:S77-S100, 2005.
125. Ramer LM, Ramer MS, Steeves JD: Setting the stage for functional repair of spinal cord injuries: A cast of thousands. Spinal Cord 43:134-161, 2005.
126. Ramon-Cueto A, Plant GW, Avila J, Bunge MB: Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci 18:3803-3815, 1998.
127. Reier PJ: Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx 1:424-451, 2004.
128. Reier PJ, Houle JD, Jakeman L, Winialski D, Tessler A: Transplantation of fetal spinal cord tissue into acute and chronic hemisection and contusion lesions of the adult rat spinal cord. Prog Brain Res 78:173-179, 1988.
129. Richardson PM, McGuinness UM, Aguayo AJ: Axons from CNS neurons regenerate into PNS grafts. Nature 284:264-265, 1980.
130. Rowed DW: Value of somatosensory evoked potentials for prognosis in partial cord injuries, in Tator CH (ed): Early Management of Acute Spinal Cord injury. New York, Raven Press, 1982, pp 167-180.
131. Rowed DW, McLean JA, Tator CH: Somatosensory evoked potentials in acute spinal cord injury: Prognostic value. Surg Neurol 9:203-210, 1978.
132. Sagen J: Cellular therapies for spinal cord injury: What will the FDA need to approve moving from the laboratory to the human? J Rehabil Res Dev 40:71-79, 2003.
133. Sato T, Kokubun S, Rijal KP, Ojima T, Moriai N, Hashimoto M, Hyodo H, Oonuma H: Prognosis of cervical spinal cord injury in correlation with magnetic resonance imaging. Paraplegia 32:81-85, 1994.
134. Schwab JM, Brechtel K, Mueller CA, Failli V, Kaps HP, Tuli SK, Schluesener HJ: Experimental strategies to promote spinal cord regeneration - An integrative perspective. Prog Neurobiol 78:91-116, 2006.
135. Schwab ME: Experimental aspects of spinal cord regeneration. Curr Opin Neurol Neurosurg 6:549-553, 1993.
136. Schwab ME: Nogo and axon regeneration. Curr Opin Neurobiol 14:118-124, 2004.
137. Schwab ME, Bartholdi D: Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 76:319-370, 1996.
138. Schwartz M, Yoles E: Macrophages and dendritic cells treatment of spinal cord injury: From the bench to the clinic. Acta Neurochir Suppl 93:147-150, 2005.
139. Selden NR, Quint DJ, Patel N, d'Arcy HS, Papadopoulos SM: Emergency magnetic resonance imaging of cervical spinal cord injuries: Clinical correlation and prognosis. Neurosurgery 44:785-793, 1999.
140. Shapiro S, Borgens R, Pascuzzi R, Roos K, Groff M, Purvines S, Rodgers RB, Hagy S, Nelson P: Oscillating field stimulation for complete spinal cord injury in humans: A phase 1 trial. J Neurosurg Spine 2:3-10, 2005.
141. Shi R, Borgens RB, Blight AR: Functional reconnection of severed mammalian spinal cord axons with polyethylene glycol. J Neurotrauma 16: 727-738, 1999.
142. Sipski ML: From the bench to the body: Key issues associated with research aimed at a cure for SCI. J Rehabil Res Dev 40:1-7, 2003.
143. Stauffer ES, Goodman FG, Nickel VL: Myelorrhaphy. Part 1. Spine 1:189-192, 1976.
144. Steeves J, Fawcett J, Tuszynski M: Report of international clinical trials workshop on spinal cord injury February 20-21, 2004, Vancouver, Canada. Spinal Cord 42:591-597, 2004.
145. Stirling DP, Khodarahmi K, Liu J, McPhail LT, McBride CB, Steeves JD, Ramer MS, Tetzlaff W: Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 24:2182-2190, 2004.
146. Stover SL, DeLisa Ja, Whiteneck GG: Spinal Cord Injury. Clinical Outcomes from the Model Systems. Gaithersburg, Aspen Publications, 1995.
147. Stover SL, DeVivo MJ, Go BK: History, implementation, and current status of the National Spinal Cord Injury Database. Arch Phys Med Rehabil 80:1365-1371, 1999.
148. Tadie M, Gaviria M, Mathe J-F, Menthonnex P, Loubert G, Lagarrigue J, Saint-Marc C, Argenson C, Kempf C, D'Arbigny P, Kamenka JM, Privat A, Carli P: Early care and treatment with a neuroprotective drug, gacyclidine, in patients with acute spinal cord injury. Rachis 15:363-376, 2003.
149. Tadie M, Liu S, Robert R, Guiheneuc P, Pereon Y, Perrouin-Verbe B, Mathe JF: Partial return of motor function in paralyzed legs after surgical bypass of the lesion site by nerve autografts three years after spinal cord injury. J Neurotrauma 19:909-916, 2002.
150. Tarasenko YI, Yu Y, Jordan PM, Bottenstein J, Wu P: Effect of growth factors on proliferation and phenotypic differentiation of human fetal neural stem cells. J Neurosci Res 78:625-636, 2004.
151. Tator C: Epidemiology and general characteristics of the spinal cord injury patient, in Benzel E, Tator CH (eds): Contemporary Management of Spinal Cord Injury. Park Ridge, American Association of Neurological Surgeons, 1995, pp 9-13.
152. Tator C: Epidemiology and general characteristics of the spinal cord injured patient, in Tator CH, Benzel E (eds): Contemporary Management of Spinal Cord Injury: From Impact to Rehabilitation. Park Ridge, American Association of Neurological Surgeons, 2000, pp 15-19.
153. Tator CH: Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 5:407-413, 1995.
154. Tator CH: Pathophysiology and pathology of spinal cord injury, in Wilkins RH, Rengachary SS (eds): Neurosurgery. New York, McGraw-Hill, 1996, pp 2847-2859.
155. Tator CH: Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery 42:696-708, 1998.
156. Tator CH: Strategies for recovery and regeneration after brain and spinal cord injury. Inj Prev 8 [Suppl 4]:IV33-IV36, 2002.
157. Tator C, Fehlings M: Clinical trials in spinal cord injury, in Biller J, Bogousslavsky J (eds): Clinical Trials in Neurologic Practice, Blue Books of Practical Neurology. Boston, Butterworth-Heinemann, 2001, pp 99-120.
158. Tator CH, Duncan EG, Edmonds VE, Lapczak LI, Andrews DF: Comparison of surgical and conservative management in 208 patients with acute spinal cord injury. Can J Neurol Sci 14:60-69, 1987.
159. Tator CH, Duncan EG, Edmonds VE, Lapczak LI, Andrews DF: Changes in epidemiology of acute spinal cord injury from 1947 to 1981. Surg Neurol 40:207-215, 1993.
160. Tator CH, Duncan EG, Edmonds VE, Lapczak LI, Andrews DF: Neurological recovery, mortality and length of stay after acute spinal cord injury associated with changes in management. Paraplegia 33:254-262, 1995.
161. Tator CH, Fehlings MG, Thorpe K, Taylor W: Current use and timing of spinal surgery for management of acute spinal surgery for management of acute spinal cord injury in North America: Results of a retrospective multicenter study. J Neurosurg 91:12-18, 1999.
162. Tator CH, Rowed DW, Schwartz ML: Sunnybrook cord injury scales for assessing neurological injury and recovery, in Tator CH (ed): Early Management of Acute Spinal Cord Injury. New York, Raven Press, 1982, pp 7-24.
163. Thomas SL, Gorassini MA: Increases in corticospinal tract function by treadmill training after incomplete spinal cord injury. J Neurophysiol 94: 2844-2855, 2005.
164. Thrasher TA, Flett HM, Popovic MR: Gait training regimen for incomplete spinal cord injury using functional electrical stimulation. Spinal Cord 44:357-361, 2006.
165. Totoiu MO, Keirstead HS: Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 486:373-383, 2005.
166. Tsai EC, Dalton PD, Shoichet MS, Tator CH: Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials 27:519-533, 2006.
167. Tsai EC, Tator CH: Neuroprotection and regeneration strategies for spinal cord repair. Curr Pharm Des 11:1211-1222, 2005.
168. Vaccaro AR, Daugherty RJ, Sheehan TP, Dante SJ, Cotler JM, Balderston RA, Herbison GJ, Northrup BE: Neurologic outcome of early versus late surgery for cervical spinal cord injury. Spine 22:2609-2613, 1997.
169. Vale FL, Burns J, Jackson AB, Hadley MN: Combined medical and surgical
170. van Hedel HJ, Wirz M, Dietz V: Assessing walking ability in subjects with spinal cord injury: Validity and reliability of 3 walking tests. Arch Phys Med Rehabil 86:190-196, 2005.
171. van Meeteren NL, Eggers R, Lankhorst AJ, Gispen WH, Hamers FP: Locomotor recovery after spinal cord contusion injury in rats is improved by spontaneous exercise. J Neurotrauma 20:1029-1037, 2003.
172. Vikhanski L: In Search of the Lost Cord: Solving the Mystery of Spinal Cord Regeneration. Washington, DC, Joseph Henry Press, 2001.
173. von Wild KR, Brunelli GA: Restoration of locomotion in paraplegics with aid of autologous bypass grafts for direct neurotisation of muscles by upper motor neurons - The future: Surgery of the spinal cord? Acta Neurochir Suppl 87:107-112, 2003.
174. Wallace MC, Tator CH, Gentles WM: Effect of alternating current stimulation of the spinal cord on recovery from acute spinal cord injury in rats. Surg Neurol 28:269-276, 1987.
175. Wells JE, Hurlbert RJ, Fehlings MG, Yong VW: Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126:1628-1637, 2003.
176. Wirth ED 3rd, Reier PJ, Fessler RG, Thompson FJ, Uthman B, Behrman A, Beard J, Vierck CJ, Anderson DK: Feasibility and safety of neural tissue transplantation in patients with syringomyelia. J Neurotrauma 18:911-929, 2001.
177. Wirz M, Zemon DH, Rupp R, Scheel A, Colombo G, Dietz V, Hornby TG: Effectiveness of automated locomotor training in patients with chronic incomplete spinal cord injury: A multicenter trial. Arch Phys Med Rehabil 86:672-680, 2005.
178. Wolfe DL, Hayes KC, Hsieh JT, Potter PJ: Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury: A double-blinded, placebo-controlled crossover trial. J Neurotrauma 18:757-771, 2001.
179. Wu P, Tarasenko YI, Gu Y, Huang LY, Coggeshall RE, Yu Y: Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat Neurosci 5:1271-1278, 2002.